David Zaccardelli, Verona Pharma CEO

FDA ap­proves new COPD drug from Verona Phar­ma

The FDA ap­proved Verona Phar­ma’s drug for chron­ic ob­struc­tive pul­monary dis­ease, or COPD, the first main­te­nance treat­ment with a new mech­a­nism for the ail­ment in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.